Human dermal fibroblasts (HDF) were isolated from the skin punch biopsy of a 25-year-old woman with Fabry disease (FD), carrying a heterozygous c.708 G > C missense mutation in the alpha-galactosidase A gene. HDF were reprogrammed to induced pluripotent stem cells (iPSC) using synthetic mRNA, preventing the alteration of the genome and retaining the original genotype. FD-W236C-iPSC (UKWNLi001-A) showed typical human embryonic stem cell (hESC)-like morphology, expressed all analyzed pluripotency-associated markers, could be differentiated into cells from all three germ layers, and demonstrated a normal female karyotype. We provide a novel patient-specific cell line, allowing further insights into the pathophysiology of FD. Resource table.
Pubmed ID: 30130681 RIS Download
Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.
This polyclonal secondary targets IgG (H+L)
View all literature mentionsThis polyclonal targets Mouse IgG (H+L)
View all literature mentionsThis recombinant targets SSEA-4
View all literature mentionsThis recombinant targets TRA-1-60
View all literature mentionsThis polyclonal targets TAGLN/Transgelin
View all literature mentionsThis monoclonal targets HNF-3beta (H-4)
View all literature mentionsThis monoclonal targets Human SOX2
View all literature mentionsThis unknown targets Pax-6
View all literature mentionsThis monoclonal targets HSP90B1
View all literature mentionsThis monoclonal targets SSEA4
View all literature mentionsThis monoclonal targets Oct-3/4
View all literature mentions